Pin your most used calculators here by clicking the star in the dropdown.
CLL-IPI
Clinical Context & Background
The CLL-IPI combines genetic, biochemical, and clinical parameters to stratify survival in CLL patients. It is useful for counseling patients and designing clinical trials.
Formula Logic
Sum of weighted points: TP53(4), IGHV(2), B2M(2), Stage(1), Age(1).Reference Data
| Risk Group | Score | 5-Year Overall Survival |
|---|---|---|
| Low Risk | 0 - 1 | 93.2% |
| Intermediate Risk | 2 - 3 | 79.3% |
| High Risk | 4 - 6 | 63.3% |
| Very High Risk | 7 - 10 | 23.3% |
Evidence-based oncology decision support. Verify with clinical guidelines.